by sarahcmay | Jul 16, 2024 | Publications
The Mirmira Lab recently published a new manuscript in Journal of Clinical Investigation entitled “Inhibition of the eukaryotic initiation factor-2-α kinase PERK decreases risk of autoimmune diabetes in mice.” Led by postdoctoral fellow Charanya...
by sarahcmay | Jan 24, 2024 | Publications
The Mirmira lab, led by first author Batoul Hammoud, MD, published a new study in Endocrinology demonstrating the effects of polyamine depletion by DENSpm on mice. Unlike DFMO (see previous study), DENSpm had only modest effects on type 1 diabetes outcomes in NOD mice...
by sarahcmay | Dec 13, 2023 | Publications
The Mirmira lab published a new study in Journal of Biological Chemistry. First author Ebru Ermis, a former lab undergraduate, found that leukotriene B4 receptor 2 (or BLT2) promotes macrophage migration during inflammation in mice and zebrafish. The next step is to...
by sarahcmay | Nov 2, 2023 | Publications
The Mirmira Lab, together with investigators at Indiana University School of Medicine, published a new study in Cell Reports Medicine that investigates α-difluoromethylornithine (DFMO) as a potential therapeutic for type 1 diabetes. In a randomized controlled trial of...
by sarahcmay | Jun 12, 2023 | Publications
The Mirmira lab recently published a new review article on non-alcoholic fatty liver disease (NAFLD) in the International Journal of Molecular Sciences. Amina Basha, MD, and Sarah May, PhD, co-first authored the manuscript.
